University Hospital Bern (Inselspital), Department of Pulmonary Medicine
Bern, 3010, Switzerland
NCT Number: NCT03823105
Validation of two devices with optical sensor in healthy participants and patients with sleep wake disorders.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Bern, 3010, Switzerland
The objective of this study is to evaluate and optimize a method of detecting sleep and sleep stages based on a new algorithm combining actigraphy and heart rate variability (measured by optical analysis of the pulse wave) to determine sleep architecture (segmented into three phases: WAKE, REM and NREM) with high accuracy compared to the gold standard polysomnography.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Patients with sleep wake disorders
Inclusion criteria
Exclusion criteria
Healthy subjects
Inclusion criteria
Exclusion criteria
Category A (ClinO). Medical study with CE-marked medical devices to photoplethysmographic measure heart rate, heart rate variability, and pulse wave and accelerometric data
Time frame: 1 night
Diagnostic accuracy of the new algorithm compared to the Gold Standard full polysomnography
Time frame: 1 night
Diagnostic accuracy of the new algorithm compared to the Gold Standard full polysomnography
Insel Gruppe AG, University Hospital Bern
Other
Validation of Non-invasive Miniature Optical Sensors for Scoring Sleep Stages: a Prospective, Method-comparison, Proof of Concept, Single-centre Phase IV Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04299490
Agnosia, Apnea
Baltimore, Maryland, United States
View Trial DetailsNCT05516524
Apnea, Dyssomnias
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT04451668
Cataplexy, Disorders of Excessive Somnolence
Birmingham, Alabama, United States
View Trial DetailsNCT03763071
Apnea, Dyssomnias
Bartın, Turkey (Türkiye)
View Trial Details